Durandy Anne, Taubenheim Nadine, Peron Sophie, Fischer Alain
Inserm, U768, Paris F-75015, France.
Adv Immunol. 2007;94:275-306. doi: 10.1016/S0065-2776(06)94009-7.
B-cell intrinsic immunoglobulin class switch recombination (Ig-CSR) deficiencies, previously termed hyper-IgM syndromes, are genetically determined conditions characterized by normal or elevated serum IgM levels and an absence or very low levels of IgG, IgA, and IgE. As a function of the molecular mechanism, the defective CSR is variably associated to a defect in the generation of somatic hypermutations (SHMs) in the Ig variable region. The study of Ig-CSR deficiencies contributed to a better delineation of the mechanisms underlying CSR and SHM, the major events of antigen-triggered antibody maturation. Four Ig-CSR deficiency phenotypes have been so far reported: the description of the activation-induced cytidine deaminase (AID) deficiency (Ig-CSR deficiency 1), caused by recessive mutations of AICDA gene, characterized by a defect in CSR and SHM, clearly established the role of AID in the induction of the Ig gene rearrangements underlying CSR and SHM. A CSR-specific function of AID has, however, been detected by the observation of a selective CSR defect caused by mutations affecting the C-terminus of AID. Ig-CSR deficiency 2 is the consequence of uracil-N-glycosylase (UNG) deficiency. Because UNG, a molecule of the base excision repair machinery, removes uracils from DNA and AID deaminates cytosines into uracils, that observation indicates that the AID-UNG pathway directly targets DNA of switch regions from the Ig heavy-chain locus to induce the CSR process. Ig-CSR deficiencies 3 and 4 are characterized by a selective CSR defect resulting from blocks at distinct steps of CSR. A further understanding of the CSR machinery is expected from their molecular definition.
B细胞内在免疫球蛋白类别转换重组(Ig-CSR)缺陷,以前称为高IgM综合征,是由基因决定的疾病,其特征是血清IgM水平正常或升高,而IgG、IgA和IgE水平缺乏或极低。根据分子机制,有缺陷的类别转换重组与Ig可变区体细胞超突变(SHM)产生缺陷存在不同程度的关联。对Ig-CSR缺陷的研究有助于更好地描绘类别转换重组和体细胞超突变的潜在机制,这是抗原触发抗体成熟的主要事件。迄今为止,已报道了四种Ig-CSR缺陷表型:由AICDA基因隐性突变引起的活化诱导胞苷脱氨酶(AID)缺陷(Ig-CSR缺陷1)的描述,其特征是类别转换重组和体细胞超突变存在缺陷,明确确立了AID在诱导类别转换重组和体细胞超突变基础的Ig基因重排中的作用。然而,通过观察影响AID C末端的突变导致的选择性类别转换重组缺陷,检测到了AID的一种类别转换重组特异性功能。Ig-CSR缺陷2是尿嘧啶-N-糖苷酶(UNG)缺陷的结果。由于UNG是碱基切除修复机制的一个分子,可从DNA中去除尿嘧啶,而AID将胞嘧啶脱氨为尿嘧啶,该观察结果表明AID-UNG途径直接靶向Ig重链基因座的转换区DNA以诱导类别转换重组过程。Ig-CSR缺陷3和4的特征是在类别转换重组的不同步骤受阻导致的选择性类别转换重组缺陷。预计通过对它们的分子定义能进一步了解类别转换重组机制。